6'-((6-Amino-4-pyrimidinyl)amino)-8'-methyl-2'H-spiro(cyclohexane-1,3'-imidazo(1,5-a)pyridine)-1',5'-dione,
eFT508,
spiro(cyclohexane-1,3'(2'H)-imidazo(1,5-a)pyridine)-1',5'-dione, 6'-((6-amino-4-pyrimidinyl)amino)-8'-methyl-,
tomivosertib,
eFT508,
Tomivosertib,
1849590-01-7,
EFT-508,
UNII-U2H19X4WBV,
U2H19X4WBV,
eFT-508 (eFT508),
6'-[(6-aminopyrimidin-4-yl)amino]-8'-methyl-2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione,
6-[(6-aminopyrimidin-4-yl)amino]-8-methylspiro[2H-imidazo[1,5-a]pyridine-3,1'-cyclohexane]-1,5-dione,
Tomivosertib [INN],
Tomivosertib [USAN],
eFT508; Tomivosertib,
CHEMBL4073443,
SCHEMBL17362622,
GTPL10167,
EFT 508,
BCP18993,
EX-A2494,
AKOS030627405,
ZINC575623807,
CS-5841,
compound 23 [PMID: 29526098],
HY-100022,
S8275,
6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-1'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'(2'H)-dione,
N45,
Spiro(cyclohexane-1,3'(2'H)-imidazo(1,5-a)pyridine)-1',5'-dione, 6'-((6-amino-4-pyrimidinyl)amino)-8'-methyl-,